Article
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis
by
Tania F. Gendron;
Jeannie Chew;
Jeannette N. Stankowski;
Lindsey R. Hayes;
Yong-Jie Zhang;
Mercedes Prudencio;
Yari Carlomagno;
Lillian M. Daughrity;
Karen Jansen-West;
Emilie A. Perkerson;
Aliesha O'Raw;
Casey Cook;
Luc Pregent;
Veronique Belzil;
Marka van Blitterswijk;
Lilia J. Tabassian;
Chris W. Lee;
Mei Yue;
Jimei Tong;
Yuping Song;
Monica Castanedes-Casey;
Linda Rousseau;
Virginia Phillips;
Dennis W. Dickson;
Rosa Rademakers;
John D. Fryer;
Beth K. Rush;
Otto Pedraza;
Ana M. Caputo;
Pamela Desaro;
Carla Palmucci;
Amelia Robertson;
Michael G. Heckman;
Nancy N. Diehl;
Edythe Wiggs;
Michael Tierney;
Laura Braun;
Jennifer Farren;
David Lacomis;
Shafeeq Ladha;
Christina Nicole Fournier;
Leo F. McCluskey;
Lauren B. Elman;
Jon B. Toledo;
Jennifer D. McBride;
Cinzia Tiloca;
Claudia Morelli;
Barbara Poletti;
Federica Solca;
Alessandro Prelle;
Joanne Wuu;
Jennifer Jockel-Balsarotti;
Frank Rigo;
Christine Ambrose;
Abhishek Datta;
Weixing Yang;
Denitza Raitcheva;
Giovanna Antognetti;
Alexander McCampbell;
John C. Van Swieten;
Bruce L. Miller;
Adam L. Boxer;
Robert H. Brown;
Robert Bowser;
Timothy Miller;
John Q. Trojanowski;
Murray Grossman;
James D. Berry;
William Hu;
Antonia Ratti;
Bryan J. Traynor;
Matthew D. Disney;
Michael Benatar;
Vincenzo Silani;
Jonathan D Glass;
Mary Kay Floeter;
Jeffrey D. Rothstein;
Kevin B. Boylan;
Leonard Petrucelli
2017